Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications

Christopher D Verrico, Colin N Haile, Thomas F Newton, Thomas R Kosten, Richard De La Garza
  • Expert Opinion on Investigational Drugs, September 2013, Informa Healthcare
  • DOI: 10.1517/13543784.2013.836488

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1517/13543784.2013.836488

The following have contributed to this page: Dr Christopher D Verrico